CANBEX THERAPEUTICS
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. Spasticity is a debilitating and painful symptom that consists of involuntary spasms and stiffness of limbs and torso. The goal of the Canbex lead programme is to improve the lives of people with this serious and incurable disorder, and set a new standard in the treatment of spasticity.
CANBEX THERAPEUTICS
Industry:
Health Care Medical Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.canbex.co.uk
Total Employee:
1+
Status:
Active
Contact:
+4402075545872
Email Addresses:
[email protected]
Total Funding:
5.1 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Google Analytics Classic
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellcome Trust
Wellcome Trust investment in Venture Round - Canbex Therapeutics
M Ventures
M Ventures investment in Venture Round - Canbex Therapeutics
UCLB
UCLB investment in Venture Round - Canbex Therapeutics
Wellcome Trust
Wellcome Trust investment in Venture Round - Canbex Therapeutics
UCLB
UCLB investment in Venture Round - Canbex Therapeutics
Esperante Ventures
Esperante Ventures investment in Venture Round - Canbex Therapeutics
Bloomsbury Bioseed Fund
Bloomsbury Bioseed Fund investment in Venture Round - Canbex Therapeutics
Official Site Inspections
http://www.canbex.co.uk
- Host name: 5.77.63.117
- IP address: 5.77.63.117
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Canbex Therapeutics"
Canbex Therapeutics - Crunchbase Company Profile & Funding
Organization. Canbex Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
Canbex Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Canbex Therapeutics. Use the PitchBook Platform to explore the full profile. Information on acquisition, …See details»
CANBEX THERAPEUTICS LIMITED - Companies House
GOV.UK Find and update company information Companies House does not verify the accuracy of the information filed (link opens a new window) ... Registers for CANBEX THERAPEUTICS …See details»
Canbex Therapeutics - Ownership and Business Overview - Mergr
Canbex Therapeutics Ltd. The Network Building, 97 Tottenham Court Road, London, W1T 4TP United Kingdom, +44(0)20 7554 5872 www.canbex.co.ukSee details»
Canbex Therapeutics Ltd Information
Canbex is a spin-out of University College London (UCL) that was established to develop its proprietary VSN compound series. In addition to its pioneering scientific founders and clinical …See details»
Canbex Therapeutics Ltd. - London, United Kingdom
Mar 25, 2011 canbex.co.uk. Contact. Profile News. Contact. About Canbex Therapeutics. Founded in 2005, Canbex Therapeutics Ltd is a spinout company from The Wolfson Institute …See details»
Canbex Therapeutics Limited - Company Profile - Endole
Canbex Therapeutics Limited is an active company incorporated on 15 March 2004 with the registered office located in London, Greater London. Canbex Therapeutics Limited has been …See details»
Canbex Therapeutics - Overview, News & Similar companies
Oct 25, 2021 Canbex Therapeutics contact info: Phone number: +44 2075545872 Website: www.canbex.co.uk What does Canbex Therapeutics do? Canbex Therapeutics is dedicated to …See details»
CANBEX THERAPEUTICS LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CANBEX THERAPEUTICS LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
Canbex Therapeutics Limited - Company Profile - Endole
Canbex Therapeutics Limited is an active company incorporated on 15 March 2004 with the registered office located in London, Greater London. Canbex Therapeutics Limited was …See details»
Canbex Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Canbex Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Drug:VSN-16R.See details»
Nextsource | Company Profile | Canbex Therapeutics
Explore the company profile of Canbex Therapeutics (canbex.co.uk) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
CANBEX THERAPEUTICS LIMITED - Companies House
CANBEX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
GtR - Research Councils UK
Oct 7, 2024 The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt thereof : (I) wherein: n is 0 or 1; R1 is selected from H, alkyl and aralkyl, …See details»
Canbex Therapeutics (United Kingdom) - Wikidata
Canbex Therapeutics (United Kingdom) (Q30268873) From Wikidata. Jump to navigation Jump to search. company in London, United Kingdom. edit. Language Label Description Also known …See details»
Canbex - VentureRadar
Canbex Therapeutics is dedicated to the development of novel compounds for the treatment of spasticity in multiple sclerosis (MS) and potentially other disorders. Supported by the US …See details»
Canbex Therapeutics completes £2.1m financing round
Apr 10, 2013 2011 news story – Canbex Therapeutics receives £1.75 million Translation Award from the Wellcome Trust; About Canbex Canbex is a single-asset company that was …See details»
£47 million announced for innovation in healthcare
Apr 9, 2013 Canbex Therapeutics Ltd – A £1.3m (project value of £1.9m) Late Stage Award will enable the first clinical studies of a novel drug for the treatment of spasticity in multiple …See details»
UCLB spin-out company, Canbex Therapeutics receives £1.75 …
Mar 23, 2011 UCLB spin-out company, Canbex Therapeutics Ltd. (Canbex) announced today that it has received a Translation Award of up to £1.75 million ($2.8 million) from the Wellcome …See details»